March 10, 2014
/PRNewswire/ -- Hill-Rom Holdings, Inc. (NYSE: HRC) announced today that
William G. Dempsey
has been elected to its Board of Directors. He currently serves as a director of Landauer, Inc., Nordion Inc., and Hospira, Inc., and previously held various executive positions with Abbott Laboratories, including Executive Vice President of Global Pharmaceuticals, Senior Vice President of Pharmaceutical Operations, and Senior Vice President of International Operations. He also previously served as Chairman of the International Section of the Pharmaceutical Research and Manufacturers of America (PhRMA) and as Chairman of the Accelerating Access Initiative, a cooperative public-private partnership of UNAIDS, the World Bank, and six research-based pharmaceutical companies.
"Bill has a wealth of experience in the health care industry that will further strengthen our Board," said
Rolf A. Classon
, Chairman of the Hill-Rom Board of Directors. "His broad senior level executive, international and operational experience will serve our shareholders and Board well."
Dempsey is also a member of the Salvation Army Advisory Board in
and the Board of Trustees for the Guadalupe Center in Immokalee Florida. He received a Bachelor of Science degree in Accounting from
ABOUT HILL-ROM HOLDINGS, INC.
Hill-Rom is a leading worldwide manufacturer and provider of medical technologies and related services for the health care industry, including patient support systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals, surgical products and information technology solutions. Hill-Rom's comprehensive product and service offerings are used by health care providers across the health care continuum and around the world in hospitals, extended care facilities and home care settings to enhance the safety and quality of patient care.